Drugs / PRV-300
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03849599 | Feb 2018 → Mar 2019 | ulcerative colitis | Provention Bio, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRV-300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849599 ↗ |
| Route | Intravenous | “via IV infusion” NCT03849599 ↗ |